College of Medicine and Health Sciences, Jigjiga University, Jijiga, Ethiopia.
School of Public Health, Haramaya University, Dire Dawa, Ethiopia.
BMC Pulm Med. 2019 Nov 6;19(1):201. doi: 10.1186/s12890-019-0971-y.
Delay in diagnosis and treatment of pulmonary tuberculosis (PTB) leads to severe disease, adverse outcomes and increased transmission. Assessing the extent of delay and its effect on disease progression in TB affected settings has clinical and programmatic importance. Hence, the aim of this study was to investigate the possible effect of delay on infectiousness (cavitation and smear positivity) of patients at diagnosis in Somali pastoralist area, Ethiopia.
A cross-sectional study was conducted between December 2017 and October 2018, and 434 newly coming and confirmed PTB patients aged ≥15 years were recruited in five facilities. Data were collected using interview, record-review, anthropometry, Acid-fast bacilli and chest radiography techniques. Log-binomial regression models were used to reveal the association of delay and other factors associated with cavitation and smear positivity, and ROC Curve was used to determine discriminative ability and threshold delays.
Median age of patients was 30 years. Of all, 62.9% were males, and 46.5% were pastoralists. Median diagnosis delay was 49 days (IQR = 33-70). Cavitation was significantly associated with diagnosis delay [P < 0.001]; 22.2% among patients diagnosed within 30 days of illness and 51.7% if delay was over 30 days. The threshold delay that optimizes cavitation was 43 days [AUC (95% CI) = 0.67(0.62-0.72)]. Smear positivity was significantly increased in patients delayed over 49 days [p = 0.02]. Other factors associated with cavitation were age ≤ 35 years [APR (95% CI) =1.3(1.01-1.6)], chronic diseases [APR (95% CI) = 1.8(1.2-2.6)] and low MUAC* [APR (95% CI) = 1.8(1.2-2.8)]. Smear positivity was also associated with age ≤ 35 years [APR (95% CI) =1.4(1.1-1.8)], low BMI [APR (95% CI) =1.3(1.01-1.7)] and low MUAC [APR (95% CI) =1.5(1.2-1.9)].
This study highlights delay in diagnosis of pulmonary TB remained high and increased infectiousness of patients in pastoral settings of Ethiopia. Hence, delay should be targeted to improve patient outcomes and reduce transmission in such settings.
肺结核(PTB)的诊断和治疗延误会导致病情加重、预后不良和传播增加。评估结核病患者延误时间及其对疾病进展的影响在临床和规划方面具有重要意义。因此,本研究旨在调查在埃塞俄比亚索马里牧民地区,诊断时的延误时间对患者传染性(空洞和涂片阳性)的可能影响。
这是一项横断面研究,于 2017 年 12 月至 2018 年 10 月在 5 个机构进行,共招募了 434 名新发病且确诊的年龄≥15 岁的肺结核患者。使用访谈、病历回顾、人体测量、抗酸杆菌和胸部 X 线技术收集数据。采用对数二项式回归模型揭示延迟与其他与空洞和涂片阳性相关的因素之间的关联,并采用 ROC 曲线确定临界延迟和区分能力。
患者的中位年龄为 30 岁。其中,62.9%为男性,46.5%为牧民。中位诊断延迟时间为 49 天(IQR=33-70)。空洞与诊断延迟显著相关[P<0.001];发病后 30 天内诊断的患者中,22.2%有空洞,而延迟超过 30 天的患者中,51.7%有空洞。优化空洞的临界延迟时间为 43 天[AUC(95%CI)=0.67(0.62-0.72)]。涂片阳性在延迟超过 49 天的患者中显著增加[P=0.02]。与空洞相关的其他因素包括年龄≤35 岁[APR(95%CI)=1.3(1.01-1.6)]、慢性病[APR(95%CI)=1.8(1.2-2.6)]和低 MUAC*[APR(95%CI)=1.8(1.2-2.8)]。涂片阳性也与年龄≤35 岁[APR(95%CI)=1.4(1.1-1.8)]、低 BMI[APR(95%CI)=1.3(1.01-1.7)]和低 MUAC[APR(95%CI)=1.5(1.2-1.9)]相关。
本研究强调了埃塞俄比亚牧民地区肺结核的诊断延误仍然很高,并且增加了患者的传染性。因此,应针对延误时间进行干预,以改善患者的预后并减少此类环境中的传播。